Monday, 14 September 2026European Markets

MERLIN PROPERTIES And MERCIALYS Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - merlin properties (mrl.ls) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
merlin properties (mrl.ls) €7.60 15% 9.59%
mercialys (mery.pa) €7.86 12.23% 5.53%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. merlin properties (mrl.ls)

15% forward dividend yield and 9.59% return on equity

merlin properties socimi, sa, one of the main real estate companies listed on the spanish stock exchange (ibex-35), has as its main activity the acquisition and management of tertiary real estate assets in the iberian peninsula. the company is a public limited company incorporated as a socimi. the main activity of the company is the acquisition, active management, operation and selective rotation of quality commercial real estate assets in the investment segment “core” and “core plus”, mainly in spain and, to a lesser extent, in portugal. the company focuses on the office, retail and logistics market.

earnings per share

as for profitability, merlin properties has a trailing twelve months eps of €0.09.

pe ratio

merlin properties has a trailing twelve months price to earnings ratio of 84.44. meaning, the purchaser of the share is investing €84.44 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.59%.

more news about merlin properties.

2. mercialys (mery.pa)

12.23% forward dividend yield and 5.53% return on equity

mercialys is one of france's leading real estate companies. it is specialized in the holding, management and transformation of retail spaces, anticipating consumer trends, on its own behalf and for third parties. at december 31, 2022, mercialys had a real estate portfolio valued at euro 3.1 billion (including transfer taxes). its portfolio of 2,087 leases represents an annualized rental base of euro 168.1 million. mercialys has been listed on the stock market since october 12, 2005 (ticker: mery) and has “siic” real estate investment trust (reit) tax status. part of the sbf 120 and euronext paris compartment b, it had 93,886,501 shares outstanding at december 31, 2022.

earnings per share

as for profitability, mercialys has a trailing twelve months eps of €0.47.

pe ratio

mercialys has a trailing twelve months price to earnings ratio of 16.73. meaning, the purchaser of the share is investing €16.73 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.53%.

volatility

mercialys's last week, last month's, and last quarter's current intraday variation average was a positive 0.04%, a negative 0.76%, and a positive 1.67%.

mercialys's highest amplitude of average volatility was 0.98% (last week), 1.73% (last month), and 1.67% (last quarter).

more news about mercialys.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com